PGEN

NASDAQ HEALTHCARE

Precigen Inc

$5.57

$0.12 (+2.11%)

Live quote

52w: $1.63 – $6.04

Loading chart…

P/E Ratio—

P/B Ratio96.02

EV/EBITDA—

Debt/Equity—

ROE-1238.66%

ROIC—

Revenue Growth146.73%

Gross Margin—

Precigen, Inc. discovers and develops the next generation of cell and gene therapies in the United States. The company is headquartered in Germantown, Maryland.

Own PGEN? Track it here.

Create a free account to add PGEN to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account